Just like people, no two cancer cells are alike. And now, scientists from the University of Surrey and SCIEX have come together and developed a method for studying the fatty content inside cells that ...
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies ...
Findings support the potential of SRC-3 gene disrupted regulatory T cells to expand the therapeutic impact of next-generation cell therapies HOUSTON, March 17, 2026 (GLOBE NEWSWIRE)-- CoRegen, Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results